[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Issa et al., 2012 - Google Patents

Simultaneous determination of paracetamol, caffeine, domperidone, ergotamine tartrate, propyphenazone, and drotaverine HCl by high performance liquid …

Issa et al., 2012

Document ID
7443961879039688552
Author
Issa Y
Hassouna M
Zayed A
Publication year
Publication venue
Journal of liquid chromatography & related technologies

External Links

Snippet

A high performance liquid chromatographic (HPLC) method was developed for the simultaneous determination of paracetamol,(acetaminophen), caffeine, domperidone, ergotamine tartrate, propyphenazone, and drotaverine HCl. The chromatography was …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/86—Signal analysis
    • G01N30/8665—Signal analysis for calibrating the measuring apparatus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
    • G06F17/30861—Retrieval from the Internet, e.g. browsers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
    • G01N30/94—Development
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/20—Handling natural language data

Similar Documents

Publication Publication Date Title
Issa et al. Simultaneous determination of paracetamol, caffeine, domperidone, ergotamine tartrate, propyphenazone, and drotaverine HCl by high performance liquid chromatography
Panda et al. Analytical Quality by Design (AQbD)-oriented RP-UFLC method for quantification of lansoprazole with superior method robustness
Elshanawane et al. Quantitative determination of telmisartan, ramipril, amlodipine besylate, and atorvastatin calcium by HPLC
El-Gindy et al. Stability-Indicating HPLC method for simultaneous determination of captopril, indapamide, and their related compounds
Arayne et al. RP-HPLC method for the quantitative determination of fexofenadine hydrochloride in coated tablets and human serum
Djurdjevic et al. Chemometric optimization of a RP‐HPLC method for the simultaneous analysis of abacavir, lamivudine, and zidovudine in tablets
Tjandrawinata et al. Bioequivalence study of two formulations of bisoprolol fumarate film-coated tablets in healthy subjects
Breier et al. Validation of UV spectrophotometric method for fexofenadine hydrochloride in pharmaceutical formulations and comparison with HPLC
Patel et al. Simultaneous determination of omeprazole and domperidone in capsules by RP‐HPLC and densitometric HPTLC
Murakami et al. Development and validation of a RP‐HPLC method to quantify omeprazole in delayed release tablets
Jain et al. Simultaneous estimation of tramadol hydrochloride, paracetamol and domperidone by RP-HPLC in tablet formulation
Pinheiro et al. Development and validation of a RP-HPLC method for Roflumilast and its degradation products
Rao et al. Simultaneous determination of omeprazole and domperidone in capsules and in vitro dissolution studies by using stability indicating uplc
Sethi et al. Development and validation of a reversed phase HPLC method for simultaneous determination of curcumin and piperine in human plasma for application in clinical pharmacological studies
Satheesh et al. Simultaneous determination of ilaprazole and its related compounds in pharmaceutical dosage forms by UPLC
Dinç et al. Chromatographic and chemometrics-assisted spectrophotometric methods for the simultaneous determination of allobarbital, adiphenine hydrochloride, and paracetamol in suppository
Hadad et al. The use of a monolithic column to improve the simultaneous determination of caffeine, paracetamol, pseudoephedrine, aspirin, dextromethorphan, chlorpheniramine in pharmaceutical formulations by HPLC–a comparison with a conventional reversed-phase silica-based column
Emami et al. Quantification of pantoprazole by high performance liquid chromatography (HPLC) method: In vitro and in vivo applications
Ibrahim et al. Liquid chromatographic determination of ergotamine tartrate in its combined tablets using fluorimetric and UV detection: Application to content uniformity testing
Tumpa et al. Quality by design determination of diclofenac potassium and its impurities by high-performance liquid chromatography
Elsayed Development and validation of a rapid HPLC method for the determination of ketotifen in pharmaceuticals
Helmy et al. Simultaneous determination of paracetamol and methocarbamol in human plasma by HPLC using UV detection with time programming: Application to pharmacokinetic study
Huang et al. Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles
Sultana et al. Liquid chromatographic method for the simultaneous determination of captopril, piroxicam, and amlodipine in bulk drug, pharmaceutical formulation, and human serum by programming the detector
Charde et al. Development and validation of high‐performance liquid chromatographic method for estimation of lercanidipine in rabbit serum